Improving Our Understanding of Suicidal Ideation in Cancer Survivors

NCT04866758 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2024-09-19

No results posted yet for this study

Summary

The goal of this project is to assess the feasibility of collecting physiological and psychological data that will allow for preliminary investigation of predictors of suicidal ideation in an ambulatory cancer population already seeking psychosocial support.

Conditions

Interventions

OTHER

Survey

All data gathered will be quantitative in nature. In addition to participant completed surveys, additional demographic, and diagnosis/treatment related information will be collected from the patient's electronic medical record via Health Data Compass. Subsequent data collected as part of the patient's standard psychosocial and cancer related care (i.e., health outcomes, future utilization of UCCC psychosocial services) will also be gathered. This subsequent data collection will not include further participation, but continued access to the patient's medical record. Protected health information collected for this project will include dates (e.g., birth dates, date of diagnosis, date since last treatment, death dates) and participant zip codes. No other identifiable data will be collected. A separate survey emailed to the participant at the end of the study will collect information regarding the participant's completion status of the survey.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH
  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Jamie Studts, PhD · University of Colorado, Denver

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-06-02
Primary Completion
2020-02-01
Completion
2020-02-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04866758 on ClinicalTrials.gov